M1 muscarinic receptor agonist (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for M1 muscarinic receptor agonist (investigational), covering 2017-06-20 to 2017-06-20. Get the full timeline:
Most recent: Clinical Trial Update: Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment [Phase 1]